Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 16 June 2006:
Vol. 312. no. 5780, p. 1584
DOI: 10.1126/science.312.5780.1584b
Prev | Table of Contents | Next

News of the Week

STEM CELL RESEARCH:
Harvard Cloners Get OK to Proceed With Caution

Constance Holden

Harvard University researchers last week were given the go-ahead to use cloning to create disease-specific lines of human embryonic stem cells, making Harvard the second U.S. academic institution to use research cloning as a tool for studying diseases such as diabetes and Parkinson's. (Read more.)

Read the Full Text

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)